Gene therapy emerges as a transformative force in ophthalmology, offering renewed hope for patients with retinal diseases. This innovative approach targets both inherited and acquired conditions, ...

The development of genetic therapeutics for both rare and common diseases is evolving rapidly, particularly in terms of local delivery to the central nervous system (CNS), including the brain and the ...

After a long day at work, Jamie Smith expected to have a normal night at home with her two sons. But when she noticed her youngest son’s eyes shaking, she knew something was wrong. At 4 months old, ...

A genetic variant carried by at least one-fifth of the population may do far more than raise the odds of developing Alzheimer ...

Among the many age-related eye conditions, age-related macular degeneration (AMD) is one of the most common causes of vision loss in patients over the age of 50. As life expectancy increases in India, ...

MeiraGTx Holdings plc (NASDAQ:MGTX) stock is trading higher after the company inked a strategic collaboration in the area of ophthalmology with Eli Lilly and Co. (NYSE:LLY). MeiraGTx will grant Lilly ...

Scientists at Oregon Health & Science University's Casey Eye Institute and Baylor College of Medicine's Cullen Eye Institute published findings from a two-year Phase I clinical trial in the journal ...

Dec 1 ( Reuters) ‌- ‌Belite Bio said on ⁠Monday ‌that its experimental ‍drug for a rare genetic eye ‌disease met the main goal in a ⁠late- stage study. (Reporting by ‍Padmanabhan ⁠Ananthan in ...

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds were identified using a virtual screening approach. Two new compounds ...

Combining artificial intelligence and genetics has allowed researchers to study the part of the eye that gives us sharp central vision in amazing detail for the first time. Researchers from the ...